Position in TNYA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,355,824
+$276,347 QoQ
Shares Held
1,834,674
+17.6% QoQ
Ownership
0.818%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 101 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. TNYA ranks #302 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in TNYA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,355,824 | 1,834,674 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,079,477 | 1,559,939 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $849,668 | 1,193,355 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,904,366 | 1,175,535 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $751,892 | 1,230,594 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $783,852 | 1,375,181 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,814,293 | 1,268,737 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,501,580 | 1,296,156 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,810,482 | 1,229,188 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,439,440 | 1,040,046 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,009,192 | 928,763 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,226,693 | 873,213 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,810,887 | 819,572 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,253,751 | 790,790 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $956,245 | 475,744 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,304,733 | 449,908 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,143,008 | 380,641 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,337,596 | 368,217 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,342,184 | 229,139 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,459,635 | 215,963 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||